Abstract:Over the course of the human lifespan, somatic DNA mutations accumulate in healthy tissues. This process has been most clearly described in blood and bone marrow, esophagus, colon and skin, but cumulative DNA damage likely affects all tissues of the body. While most acquired genetic variants have no discernable functional consequences, some randomly occurring somatic mutations confer a relative fitness advantage on a single stem cell and its progeny compared to surrounding cells, which may lead to progressive expansion of a clone (i.e., a genetically identical group of cells). When these mutations occur in a cell with the capacity to self-renew and expand, the mutations persist, and such clonal expansion is a risk factor for further mutation acquisition and clonal evolution.Hematopoietic stem cells are a special case of clonal expansion, because both the stem cells and their blood cell progeny circulate in large numbers, and these cells are not subject to some of the anatomical restrictions that characterize other tissues in which somatic mutations conferring a fitness advantage also occur. Therefore, clonally restricted hematopoiesis can have biological and clinical consequences that are distinct from clonal expansions in other tissues. Such consequences include not just clonal progression to overt myeloid neoplasia (or, less commonly, to lymphoid neoplasia) driven by acquisition of secondary mutations in the cells of the expanded clone, but also cardiovascular events, as described further below – and most likely other diseases that are influenced by aberrant function of mutant blood cells.If we can understand in more detail how clonal hematopoiesis arises and how clonal selection and expansion occur, as well as develop strategies to avert the clinical consequences associated with clonal hematopoiesis, this may both improve public health and yield more general insights into the biology of aging.

The rise and rise of mitochondrial DNA mutations

Stochastic Models for Evolving Cellular Populations of Mitochondria: Disease, Development, and Ageing

On the Timing and the Extent of Clonal Expansion of Mtdna Deletions: Evidence from Single-Molecule Pcr

Survival of the densest accounts for the expansion of mitochondrial mutations in ageing

Human stem cell aging: do mitochondrial DNA mutations have a causal role?

Mitochondrial Network State Scales mtDNA Genetic Dynamics

Mitochondrial haplotype and mito-nuclear matching drive somatic mutation and selection throughout ageing

The longitudinal dynamics and natural history of clonal haematopoiesis

Mitochondrial DNA, Mitochondria, Disease and Stem Cells

Mitochondrial abnormalities in muscle and other aging cells: Classification, causes, and effects

Longitudinal change in mitochondrial heteroplasmy exhibits positive selection for deleterious variants

Mitochondrial Russian doll genes may explain some discrepancies in links between mtDNA mutations and mitochondrial diseases

Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease

Clonal hematopoiesis as a model for premalignant changes during aging

Inheritance of mitochondrial DNA in humans: implications for rare and common diseases

Selection promotes age-dependent degeneration of the mitochondrial genome

Evolution of Cell-to-Cell Variability in Stochastic, Controlled, Heteroplasmic mtDNA Populations

Single-Cell Technologies for Studying the Evolution and Function of Mitochondrial DNA Heteroplasmy in Cancer

Origins of tissue and cell-type specificity in mitochondrial DNA (mtDNA) disease

[Research Advances in Human Mitochondrial DNA with Aging and Degenerative Diseases].

Electrophile and Oxidant Damage of Mitochondrial Dna Leading to Rapid Evolution of Homoplasmic Mutations